January 13, 2020 / 7:43 PM / 7 days ago

BRIEF-Illumina And Roche Partner To Broaden Patient Access To Genomic Testing

Jan 13 (Reuters) - Illumina Inc:

* ILLUMINA AND ROCHE PARTNER TO BROADEN PATIENT ACCESS TO GENOMIC TESTING

* ILLUMINA INC - FINANCIAL TERMS OF DEAL WERE NOT DISCLOSED

* ILLUMINA - UNDER TERMS , ROCHE WILL DEVELOP, MANUFACTURE & COMMERCIALIZE AVENIO IVD TESTS FOR BOTH TISSUE & BLOOD FOR USE ON CO’S NEXTSEQ 550DX SYSTEM

* ILLUMINA INC - CO WILL CONTINUE TO SELL NEXTSEQ 550DX SYSTEMS AND CORE SEQUENCING CONSUMABLES

* ILLUMINA - ANNOUNCED 15 YEAR, NON-EXCLUSIVE COLLABORATION AGREEMENT WITH ROCHE

* ILLUMINA - WILL LEAD DEVELOPMENT AND REGULATORY APPROVAL PROCESS, AND WILL CONTINUE TO MANUFACTURE, SUPPLY AND COMMERCIALIZE TSO 500 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below